Analysis of hereditary cancer cases (732 BC patients, 189 CRC patients, and 490 cancer-free elderly controls) revealed that 1% presented concurrent germline pathogenic variants in BRCA1, BRCA2, MUTYH, ATM, CHECK2, NBN, and RAD50 [37]. This evidence concerns the gene BRCA2 and cancer.